Participants 1020 1108 5
patients with suspected CHD (pretest likelihood 10%-90%) requiring further investigation
Participants 1110 1471 6
A total of 1,200 patients will be randomized on a 2:2:1 basis to receive 3.0-T cardiovascular magnetic resonance-guided care, single-photon emission computed tomography-guided care (according to American College of Cardiology/American Heart Association appropriate-use criteria), or National Institute for Health and Care Excellence guidelines-based management.
